中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2019, Vol. 48 ›› Issue (1): 62-65.doi: 10.12007/j.issn.0258-4646.2019.01.013

• 论著 • 上一篇    下一篇

乳腺癌患者口服他莫昔芬后子宫内膜异常的临床意义

田东立, 李丰鑫, 邓雷, 宋斐然, 庞晓燕, 张颐   

  1. 中国医科大学附属第一医院妇科, 沈阳 110001
  • 收稿日期:2018-07-18 出版日期:2019-01-30 发布日期:2019-01-05
  • 通讯作者: 张颐 E-mail:syzi@163.com
  • 作者简介:田东立(1993-),女,硕士研究生.
  • 基金资助:
    沈阳市科技计划(17-231-1-54)

Clinical Significance of Endometrial Abnormalities in Patients with Breast Cancer after Oral Administration of Tamoxifen

TIAN Dongli, LI Fengxin, DENG Lei, SONG Feiran, PANG Xiaoyan, ZHANG Yi   

  1. Department of Gynecology, The First Hospital, China Medical University, Shenyang 110001, China
  • Received:2018-07-18 Online:2019-01-30 Published:2019-01-05

摘要: 目的 分析乳腺癌患者口服他莫昔芬(TAM)后子宫内膜异常的临床意义,探讨子宫内膜恶变的高危因素。方法 收集2011年9月至2017年12月中国医科大学附属第一医院收治的乳腺癌术后口服TAM因子宫内膜异常于妇科手术治疗的患者135例,根据术后病理将患者分为子宫内膜良性病变组(A组)和子宫内膜癌前病变及恶性病变组(B组)。比较2组患者年龄、绝经状态、体质量指数、子宫内膜厚度、异常子宫出血、口服TAM剂量、口服TAM时间、合并高血压及糖尿病等因素与子宫内膜恶变的关系。结果 A组患者124例,B组患者11例。2组比较,异常子宫出血发生率的差异有统计学意义(P<0.05),且为子宫内膜恶变的危险因素。结论 乳腺癌术后口服TAM出现异常子宫出血应警惕子宫内膜恶变,首选宫腔镜明确病变性质,无症状患者可随访观察。

关键词: 他莫昔芬, 子宫内膜病变, 异常子宫出血

Abstract: Objective To analyze the clinical significance of endometrial abnormalities in patients with breast cancer after oral administration of tamoxifen,and to determine the risk factors for endometrial malignancy. Methods We collected data from 135 patients with breast cancer who underwent surgery for endometrial abnormalities after oral administration of tamoxifen at the Department of Gynecology from September 2011 to December 2017. According to the pathological results obtained,the patients were divided into groups A (benign endometrial lesion) and B (precancerous and malignant endometrial lesion). The relationships between endometrial malignancy and factors including age,menopausal status,body mass index,endometrial thickness,abnormal uterine bleeding,oral dose of tamoxifen,duration of oral medication,and complications (hypertension and diabetes) were compared between the groups. Results There were 124 patients in group A and 11 patients in group B. The difference in the incidence of abnormal uterine bleeding,which was a risk factor for endometrial malignancy,was significant different between the groups (P<0.05). Conclusion Physicians should pay close attention to abnormal uterine bleeding in patients taking tamoxifen after surgery for breast cancer. Hysteroscopy should be used to confirm the nature of lesions,and patients without symptoms should be followed up.

Key words: tamoxifen, endometrial diseases, abnormal uterine bleeding

中图分类号: 

  • R711.32
[1] FIGG WD,COOK K,CLARKE R. Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer[J]. Cancer Biol Ther,2014,15(12):1586-1587. DOI:10.4161/15384047.2014.972783.
[2] SHI AA,LEE SI. Radiological reasoning:algorithmic workup of abnormal vaginal bleeding with endovaginal sonography and sonohysterography[J]. Am J Roentgenol,2008,191(6 Suppl):S68-S73. DOI:10.2214/ajr.07.7067.
[3] FREED OC,FLETCHER GG,GANDH S,et a1. Adjuvant endocrine therapy for early breast cancer:a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline[J]. Curr Onco1,2015,22(Suppl 1):S95-S113. DOI:10.3747/co.22.2326.
[4] DAVIES C,PAN H,GODWIN J,et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of estrogen receptor-positive breast cancer:ATLAS,a randomised trial[J]. Lancet,2013,381(9869):805-816. DOI:10.3410/f.717969556.793480576.
[5] CHEN JY,KUO SJ,LIAW YP,et al. Endometrial cancer incidence in breast cancer patients correlating with age and duration of tamoxifen use:a population based study[J]. J Cancer,2014,5(2):151-155. DOI:10.7150/jca.8412.
[6] RONG HU,HILAKIVICLARKE L,Clarke R. Molecular mechanisms of tamoxifen-associated endometrial cancer (review)[J]. Oncol Lett,2015,9(4):1495-1501. DOI:10.3892/ol.2015.2962.
[7] COMMITEE ON GENECOLOGIC PRACTICE. Committee Opinion No. 601:tamoxifen and uterine cancer[J]. Obstet Gynecol,2014,123(6):1394-1397. DOI:10.1097/01.aog.0000450757.18294.cf.
[8] POLIN SA,ASCHER SM. The effect of tamoxifen on the genital tract[J]. Cancer Imaging,2008,8(1):135-145. DOI/10.1102/1470-7330.2008.0020.
[9] 李新君,王胜普. 乳腺癌术后他莫昔芬辅助治疗所致妇科并发症及其处理[J]. 实用妇产科杂志,2016,32(10):738-741.
[10] WOLFMAN W,LEYLANDEY N,HEYWOOD M,et al. A symptomatic endometrial thickening[J]. J Obstet Gynaecol Can,2010,32(10):990-999. DOI:10.1016/s1701-2163(16) 34690-4.
[11] YASA C,DURAL O,BASTU E,et al. Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women[J]. Arch Gynecol Obstet,2016,294(2):311-316. DOI:10.1007/s00404-016-4054-5.
[12] JEON SJ,LEE JI,LEE M,et al. Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen[J]. Obstet Gynecol Sci,2017,60(1):26-31. DOI:10.5468/ogs.2017.60.1.26.
[13] SACCARDI C,GIZZO S,PATRELLI TS,et al. Endometrial surveillance in tamoxifen users:role,timing and accuracy of hysteroscopic investigation:observational longitudinal cohort study[J]. Endocr Relat Cancer,2013,20(4):455-462. DOI:10.1530/ERC-13-0020.
[14] LOIACONO RM,TROJANO G,DEL GAUDIO N,et al. Hysteroscopy as a valid tool for endometrial pathology in patients with postmenopausal bleeding or asymptomatic patients with a thickened endometrium:hysteroscopic and histological results[J]. Gynecol Obstet Invest,2015,79(3):210-216. DOI:10.1159/000371758.
[1] 李丰鑫, 窦磊, 田东立, 吴广平, 庞晓燕, 张颐. 子宫内膜病变筛查中负压型子宫内膜取样器的应用价值[J]. 中国医科大学学报, 2018, 47(12): 1116-1118,1132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 黄波, 李强, 张景国, 韩晓光, 刘君, 何莲, 刘也夫. 胆囊腺瘤癌变过程及免疫表型P53的诊断价值[J]. 中国医科大学学报, 2009, 38(9): 703 .
[2] 初立伟, 杨茂伟, 于江, 王铜浩, 李亚伦. 锌对大鼠生长板软骨细胞ZnT-7表达的影响[J]. 中国医科大学学报, 2009, 38(10): 727 .
[3] 张丽, 齐瑞群, 孙艳, 陈国红, 任宏伟, 陈洪铎, 高兴华. 卡介菌多糖核酸对特应性皮炎外周血CLA~+T细胞表达不同细胞因子的影响[J]. 中国医科大学学报, 2009, 38(10): 764 .
[4] 李春辉, 何群, 马静红, 潘忠诚, 王天骄, 张玉魁, 赵雨杰. 应用凝集素芯片检测胃正常黏膜上皮细胞与胃癌细胞膜表面糖链表达[J]. 中国医科大学学报, 2009, 38(11): 807 .
[5] 张梅英, 吴红联, 蔺美娜, 李兆阳, 周生来, 于洋, 王惟, 吕相川, 王禄增. 突变DJ-1转基因小鼠模型的建立[J]. 中国医科大学学报, 2009, 38(11): 820 .
[6] 陈波, 金锋, 姚凡, 刘彩刚. beclin-1基因在乳腺癌中的表达及其与临床病理因素的关系[J]. 中国医科大学学报, 2009, 38(12): 916 .
[7] 庞晓燕, 张颐, 郭科军. 子宫内膜透明细胞癌的临床分析[J]. 中国医科大学学报, 2009, 38(12): 921 .
[8] 韩丽萍, 王秋月, 麦洪珍, 侯刚, 康健. 慢性阻塞性肺疾病患者血清IL-8、hsCRP水平及临床意义的探讨[J]. 中国医科大学学报, 2009, 38(12): 924 .
[9] 马秀岚, 李巍, 季文樾, 王宏伟, 边志刚, 顾兆伟. 先天性舌根囊肿的临床分析[J]. 中国医科大学学报, 2009, 38(12): 943 .
[10] 于雪馨, 王常林, 孙荣国, 杨屹. 鼠输尿管完全梗阻后肾脏病理及足细胞表型改变的研究[J]. 中国医科大学学报, 2010, 39(1): 1 .

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA